STOCK TITAN

BeiGene, Ltd. American Depositary Shares - ONC STOCK NEWS

Welcome to our dedicated page for BeiGene, Ltd. American Depositary Shares news (Ticker: ONC), a resource for investors and traders seeking the latest updates and insights on BeiGene, Ltd. American Depositary Shares stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BeiGene, Ltd. American Depositary Shares's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BeiGene, Ltd. American Depositary Shares's position in the market.

Rhea-AI Summary

BeiGene (NASDAQ: ONC) has appointed Giancarlo Benelli as Senior Vice President and Head of Europe, effective January 1st. The company, which plans to change its name to BeOne Medicines , aims to strengthen its European presence through this strategic appointment. Benelli brings over 20 years of pharmaceutical industry experience from positions at Novartis and AstraZeneca, most recently serving as Vice President and Head Radioligand Therapy International Markets at Novartis.

Benelli will lead BeiGene's European operations from Basel, Switzerland, overseeing more than 800 colleagues across the region. His previous experience includes serving as General Manager at Advanced Accelerators Applications, where he managed post-acquisition restructuring and successful product launches. He holds a Medical Doctorate and Post Graduate Diploma in Thoracic Surgery from the University of Genoa, and a Diploma in Health Economics from the University of York.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.1%
Tags
management

FAQ

What is the current stock price of BeiGene, Ltd. American Depositary Shares (ONC)?

The current stock price of BeiGene, Ltd. American Depositary Shares (ONC) is $176.71 as of January 10, 2025.

What is the market cap of BeiGene, Ltd. American Depositary Shares (ONC)?

The market cap of BeiGene, Ltd. American Depositary Shares (ONC) is approximately 18.8B.
BeiGene, Ltd. American Depositary Shares

Nasdaq:ONC

ONC Rankings

ONC Stock Data

18.82B
87.65M
19.43%
46.91%
1.29%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
GRAND CAYMAN